Von Willebrand's disorder is caused by a deficiency (type 1) or an abnormality (type 2) of von Willebrand factor. It is the commonest of the inherited bleeding disorders, occurring in about 1 in 1000 of the population. Occasionally a severe disorder, von Willebrand's disorder (type 3) can occur. It has similar symptoms to Haemophilia.
Von Willebrand's disorder differs in a number of respects from haemophilia.
Joint bleeds are uncommon and most people experience excessive bruising, bleeding from mucous membranes such as nose bleeds and bleeding following some types of surgery or dental extractions. In women, heavy periods may be experienced.
Treatment for von Willebrand's disorder varies depending on the type (1,2,or
3) and the severity based on symptoms and results of blood tests.
In those with Type1 von Willebrand's disorder and mild reductions in von Willebrand
factor, a drug DDAVP (desmopressin acetate) is given intravenously to stimulate
the release of von Willebrand factor into the circulation and prevents or
treats bleeding. This infusion may need to be repeated. Intravenous Factor V111 concentrate can be used in cases where DDAVP is not effective. Tranexamic acid tablets are often helpful in women who are experiencing heavy periods..
This page last updated: November 2004
Review date: June 2005